BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $29.26 million. The enterprise value is -$1.09 million.

Market Cap	29.26M
Enterprise Value	-1.09M

Important Dates

The next estimated earnings date is Monday, June 15, 2026, after market close.

Earnings Date	Jun 15, 2026
Ex-Dividend Date	n/a

Share Statistics

BCTX has 7.25 million shares outstanding. The number of shares has increased by 784.70% in one year.

Current Share Class	7.25M
Shares Outstanding	7.25M
Shares Change (YoY)	+784.70%
Shares Change (QoQ)	+48.75%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	3.29%
Float	6.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.97
P/TBV Ratio	0.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.10

Current Ratio	10.10
Quick Ratio	9.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-831.19

Financial Efficiency

Return on equity (ROE) is -179.21% and return on invested capital (ROIC) is -114.89%.

Return on Equity (ROE)	-179.21%
Return on Assets (ROA)	-89.44%
Return on Invested Capital (ROIC)	-114.89%
Return on Capital Employed (ROCE)	-101.08%
Weighted Average Cost of Capital (WACC)	13.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.19% in the last 52 weeks. The beta is 1.63, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	-92.19%
50-Day Moving Average	4.12
200-Day Moving Average	7.53
Relative Strength Index (RSI)	47.15
Average Volume (20 Days)	160,041

Short Selling Information

The latest short interest is 227,052, so 3.13% of the outstanding shares have been sold short.

Short Interest	227,052
Short Previous Month	282,815
Short % of Shares Out	3.13%
Short % of Float	3.54%
Short Ratio (days to cover)	1.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.74M
Pretax Income	-29.96M
Net Income	-29.64M
EBITDA	-30.63M
EBIT	-30.74M
Earnings Per Share (EPS)	-$19.98

Full Income Statement

Balance Sheet

The company has $29.90 million in cash and n/a in debt, giving a net cash position of $29.90 million or $4.12 per share.

Cash & Cash Equivalents	29.90M
Total Debt	n/a
Net Cash	29.90M
Net Cash Per Share	$4.12
Equity (Book Value)	30.21M
Book Value Per Share	4.26
Working Capital	28.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-30.97M
Capital Expenditures	n/a
Depreciation & Amortization	106,627
Net Borrowing	n/a
Free Cash Flow	-30.97M
FCF Per Share	-$4.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-784.70%
Shareholder Yield	-784.70%
Earnings Yield	-101.28%
FCF Yield	-105.83%

Analyst Forecast

The average price target for BCTX is $40.00, which is 885.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.00
Price Target Difference	885.22%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-66.89%

Stock Forecasts

Stock Splits

The last stock split was on August 25, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 25, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1